Abstract:In light of extensive work that has created a wide range of techniques for predicting the course of multiple sclerosis (MS) disease, this paper attempts to provide an overview of these approaches and put forth an alternative way to predict the disease progression. For this purpose, the existing methods for estimating and predicting the course of the disease have been categorized into clinical, radiological, biological, and computational or artificial intelligence-based markers. Weighing the weaknesses and strengths of these prognostic groups is a profound method that is yet in need and works directly at the level of diseased connectivity. Therefore, we propose using the computational models in combination with established connectomes as a predictive tool for MS disease trajectories. The fundamental conduction-based Hodgkin-Huxley model emerged as promising from examining these studies. The advantage of the Hodgkin-Huxley model is that certain properties of connectomes, such as neuronal connection weights, spatial distances, and adjustments of signal transmission rates, can be taken into account. It is precisely these properties that are particularly altered in MS and that have strong implications for processing, transmission, and interactions of neuronal signaling patterns. The Hodgkin-Huxley (HH) equations as a point-neuron model are used for signal propagation inside a small network. The objective is to change the conduction parameter of the neuron model, replicate the changes in myelin properties in MS and observe the dynamics of the signal propagation across the network. The model is initially validated for different lengths, conduction values, and connection weights through three nodal connections. Later, these individual factors are incorporated into a small network and simulated to mimic the condition of MS. The signal propagation pattern is observed after inducing changes in conduction parameters at certain nodes in the network and compared against a control model pattern obtained before the changes are applied to the network. The signal propagation pattern varies as expected by adapting to the input conditions. Similarly, when the model is applied to a connectome, the pattern changes could give an insight into disease progression. This approach has opened up a new path to explore the progression of the disease in MS. The work is in its preliminary state, but with a future vision to apply this method in a connectome, providing a better clinical tool.

A reaction-diffusion model for relapsing-remitting multiple sclerosis with a treatment term

Reaction-diffusion systems derived from kinetic theory for Multiple Sclerosis

A chemotaxis reaction-diffusion model for Multiple Sclerosis with Allee effect

Cytokine-induced instabilities in a reaction–diffusion-chemotaxis model of Multiple Sclerosis: Bifurcation analysis and well-posedness

Relapsing/remitting multiple sclerosis: A speculative model and its implications for a novel treatment

On a chemotaxis model with nonlinear diffusion modelling multiple sclerosis

Multiple Sclerosis disease: a computational approach for investigating its drug interactions

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target

Towards Treating Multiple Sclerosis Progression

Are There General Features of How Immune Responses Are Regulated That Can Provide Clues to How Remitting/Relapsing Multiple Sclerosis May Be Treated?

Alzheimer's disease: a mathematical model for onset and progression

Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances

A reaction-diffusion model for Mycobacterium tuberculosis infection

A sensitivity analysis of a mathematical model for the synergistic interplay of Amyloid beta and tau on the dynamics of Alzheimer's disease

Generation of a Model to Predict Differentiation and Migration of Lymphocyte Subsets under Homeostatic and CNS Autoinflammatory Conditions

Multiple sclerosis: pathogenesis and treatment

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation

Modeling and simulation for prediction of multiple sclerosis progression: A review and perspective

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis

Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis